Definium Therapeutics, Inc. (MNMD)
NASDAQ · Healthcare
Definium Therapeutics, Inc. Income Statement 2020–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|
| Revenues | ||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | — | — | — | — | — | — |
| Profitability | ||||||
| Operating Income | -166.3M | -103.9M | -93.9M | -66.3M | -93.9M | -33.0M |
| EBITDA | -155.3M | -91.8M | -84.2M | -71.2M | -91.2M | -33.0M |
| Net Income | -183.8M | -108.7M | -95.7M | -56.8M | -93.0M | -33.9M |
| Per Share Data | ||||||
| EPS (diluted) | — | $-1.54 | $-2.44 | $-1.84 | $-3.45 | $-1.95 |
| Shares Outstanding (dil.) | — | 70M | 39M | 31M | 27M | 18M |
Definium Therapeutics, Inc. Income Statement — FAQ
Definium Therapeutics, Inc. (MNMD) income statement over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see MNMD's income statement history?
The chart and table above show Definium Therapeutics, Inc.'s income statement by year and by quarter, including the growth rate.